NCT02854319View on ClinicalTrials.gov

REpositionable Percutaneous Replacement of NatIve StEnotic Aortic Valve Through Implantation of LOTUS EDGE Valve System

NATerminatedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

September 7, 2016

Primary Completion Date

October 25, 2016

Study Completion Date

March 13, 2018

Conditions
Aortic Valve Stenosis
Interventions
DEVICE

LOTUS Edge Valve System

Transcatheter Aortic Valve Implantation (TAVI) with the LOTUS Edge™ Valve System when used with the Lotus™ or iSleeve™ Introducer Set

Trial Locations (3)

Unknown

Rigshospitalet, Copenhagen

Clinique Pasteur, Toulouse

Skåne University Hospital, Lund

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY